Tag results:
IL-6
Pulmonary Cell News
Ethyl Ferulate Protects against Lipopolysaccharide-Induced Acute Lung Injury by Activating AMPK/Nrf2 Signaling Pathway
[Acta Pharmacologica Sinica] Researchers found that ethyl ferulate significantly alleviated lipopolysaccharide-induced pathological damage and neutrophil infiltration and inhibited the gene expression of proinflammatory cytokines in murine lung tissues.
Prostate Cell News
Green Nanotechnology of MGF-AuNPs for Immunomodulatory Intervention in Prostate Cancer Therapy
[Scientific Reports] Investigators reported Mangiferin functionalized gold nanoparticulate agent and its immunomodulatory characteristics in treating prostate cancer.
Cancer Stem Cell News
Adipose Stem Cell Niche Reprograms the Colorectal Cancer Stem Cell Metastatic Machinery
[Nature Communications] Visceral adipose-derived factors promoted vasculogenesis and the onset of metastatic dissemination by activation of STAT3, which inhibited miR-200a and enhanced ZEB2 expression, effectively reprogramming colorectal cancer cells into a highly metastatic phenotype.
Human Immunology News
Melatonin as an Immunomodulator in Children with Down Syndrome
[Pediatric Research] Scientists demonstrated that melatonin had several significant effects by reducing CD11b and TLR4 expression, attenuating TLR signaling, genes involved in the inflammasome and had the potential to reduce LPS-induced inflammatory responses.
Intestinal Cell News
The IL-33-ILC2 Pathway Protects from Amebic Colitis
[Mucosal Immunology] Through transcriptomics analysis, we observed that Entamoeba histolytica infection was associated with increased expression of IL-33 mRNA in both the human and murine colon.
Cancer Stem Cell News
CAFs Shape Myeloid-Derived Suppressor Cells to Promote Stemness of Intrahepatic Cholangiocarcinoma via 5-Lipoxygenase
[Hepatology] Researchers investigated whether and how cancer-associated fibroblasts (CAFs) regulated myeloid-derived suppressor cells function to enhance cancer stemness, the driving force of the cancer aggressiveness and chemotherapy refractoriness, in highly desmoplastic intrahepatic cholangiocarcinoma.